Thursday, January 13, 2005

Cells Don Festive Holiday Colors

The latest holiday gifts being offered to the scientific community this season by scientists in the laboratory of Howard Hughes Medical Institute investigator Roger Y. Tsien come in a dazzling variety of hues — cherry, strawberry, tangerine, tomato, orange, banana and honeydew. The color spectrum would make Pantone proud....click more
No, Tsien's group is not giving out fruit baskets; the names describe vibrant new varieties of fluorescent protein that the researchers have created to tag cells and observe a range of cellular processes.

By splicing the genes for the fluorescent proteins into specific genes in the cell, researchers can detect when those genes are switched on to produce proteins. They can then use the telltale fluorescent colors to separate the cells visually. The availability of the new colors will enable scientists to track the effects of multiple genetic alterations in a single cell.

Tsien and his colleagues at the University of California, San Diego, published a research article describing the new fluorescent proteins in the December 2004 issue of the journal Nature Biotechnology. Lead author on the paper was HHMI predoctoral fellow Nathan C. Shaner in Tsien's laboratory. In separate studies, Tsien's team “borrowed” the immune system's machinery for generating antibody diversity and used it to evolve a new red fluorescent protein. (To read about those studies, please go to http://www.hhmi.org/news/tsien.html).

In addition to offering fluorescent proteins in a range of distinctive colors, Tsien's group has improved their design, creating proteins that are “monomers” that consist of only single protein units. Fluorescent proteins found in nature with yellow to red colors are invariably four-unit agglomerations that are often toxic or disruptive when fused to proteins that scientists hope to track.

“The analogy is that if you have a detective who is supposed to be tracking suspects, and that detective has to go around in groups of four and track four suspects at once, the suspects are likely to know something is up,” said Tsien.

The latest collection of fluorescent proteins builds on the researchers' earlier success in reengineering a four-unit fluorescent protein isolated from a coral-like creature of the species Discosoma. From that multimeric protein, the researchers engineered a monomeric protein, called mRFP1, which still retained fluorescent properties. However, certain of these properties were still not optimal for a fluorescent marker.

Shaner, Tsien and their colleagues set out to improve mRFP1's fluorescent properties — making strategic mutations in the gene for the protein — to render it more useful as a biological marker. “Basically, we were trying to guess from the crystal structure of the protein or from past knowledge of mutations, where we might make useful mutations,” said Tsien. “In the process of trying to fix these characteristics, we also discovered more colors,” he said. Further adjustments to the genes pushed the fluorescence of some of the proteins to longer wavelengths, filling in gaps in the spectrum of colors, said Tsien.

In the Nature Biotechnology article, the researchers also reported a demonstration of the improved functionality of the new proteins. They fused the protein mCherry (the “m” stands for monomeric) to proteins that were part of the cell's microtubule transport system, and of the cell's structural cytoskeleton. In both cases, mCherry successfully labeled the cellular structures. However, in the case of the microtubule protein, mRFP1 did not label it properly.

The researchers also created a red protein “tdTomato” in which two subunits still stick to each other, but they have been permanently joined head to tail. The resulting monolithic unit has no tendency to aggregate further, yet it fluoresces more brightly and resists fading better than true monomers. But in some cellular applications their larger molecular weight might interfere with cellular processes, said Tsien. And Tsien's team has engineered other fluorescent proteins that may be more or less sensitive to changes in acidity.

Tsien said such a variety of fluorescent proteins will enable scientists to have considerable choices in making such tradeoffs, “and one of the reasons we name the proteins after fruits is to remind people that there is no `best fruit' in the grocery store,” he said.

According to Tsien, the new assortment of fluorescent proteins will give researchers an easier way to track the effects of multiple genetic alterations in the same cells. “They can be applied to single cells, where you want to track different proteins, to different organelles, all the way up to whole animals,” he said.

Future efforts will aim not only at developing monomeric proteins with new colors, said Tsien, but also working on those with more complicated properties, such as the ability to change color under different conditions. His ultimate goal, he said, is to broaden the range of tools that biologists have at their disposal to track genetically altered proteins and cells.

Editor's Note: The original news release can be found here.


--------------------------------------------------------------------------------

This story has been adapted from a news release issued by Howard Hughes Medical Institute.



Read more!

Wednesday, January 12, 2005

Red And Processed Meat Linked To Colon Cancer

Red And Processed Meat Linked To Colon Cancer: "Red And Processed Meat Linked To Colon Cancer
January 13, 2005
People who consume large quantities of red and processed meats are at an increased risk of developing colon cancer, and in some cases, by as much as 50 percent, according to a new study.
The American Cancer Society study surveyed close to 150,00 people ages 50 to 74 about their health and eating habits.
The findings appear in the Journal of the American Medical Association.

The study showed that people who consumed high amounts of red and processed meat over a long period of time had a 50 percent higher risk of developing colon cancer, compared with those eating the least.
Red meat was defined as beef, pork and lamb. Processed meat included bacon and bologna.
The researchers described high red meat consumption for men as 3 ounces per day, and 2 ounces per day for women.
Now for some good news. The study found chicken and fish consumption actually lowered the risk of developing colon cancer."

Read more!

Gizmodo : Samsung SCH-S310: Motion Sensing Phone in Three Dimensions

Gizmodo : Samsung SCH-S310: Motion Sensing Phone in Three Dimensions: "Samsung has developed a new six-axis sensor that allows their new cell phone to detect motion, allowing users to write the numbers they are dialing or the characters they are typing in the air. The SCH-S310 will hit the market in March, they say, where it will be sure to embarrass a fair number of its users before they give up and just use the keypad in public. It's a slick idea, though, and should appeal greatly to the LARPing/Lightning Bolt! set who long to make anything�oh Jesus, just one little, measly thing�actually happen when they wave their arms in ancient inscriptions upon the aether.
Samsung's Motion-Recognition Phone: SCH-S310 [Slashphone]"

Read more!

Monday, January 10, 2005

First Nanotechnology Drug Approved for Breast Cancer

The government has just approved the first ever chemotherapy drug that uses nanotechnology to fight metastatic breast cancer. It's called Abraxane. It replaces toxic chemical treatment, with tiny packages of the drug paclitaxel and the natural protein albumin.
Researchers say the cancer cells believe they're taking in nutrients to help them grow, when they're really taking in the cancer fighting drug. Annice O'Brien took part in the study, 'It made me once again feel like i'm going to beat this.'
Dr. William Gradishar, Northwestern University, 'Abraxane is a new effective chemotherarpy drug for the treatment of metastatic breast cancer that can be administered over a very short period of time, and is well tolerated by patients.'
The drug offfers new hope for more than 215,000 women diagnosed with maglignant breast cancer each year.

Read more!